Pioneering cellular medicines for women’s health
We’re developing off-the-shelf cell therapies for high-impact women’s diseases, with lead programs in ovarian cancer, triple negative breast cancer and endometriosis.
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.
Some of our partners
Latest news
Bio Connections Australia 2023 promotes science commercialisation
By Christine Filippis / July 31, 2023
Commercialising science and technology is key to the continued growth of Australia’s vibrant life sciences industry. Translating research into real-world...
Read More
Australia – China Science and Innovation Forum fosters collaboration and commercialisation
By Christine Filippis / June 28, 2023
The 2023 Australia-China Science and Innovation Forum focused on leading-edge Australian and Chinese biomedical research collaborations and commercialisation. The forum...
Read More
Cell Therapy Potency Assay Summit reveals exclusive insights on regulatory interactions and potency assay development
By Christine Filippis / June 16, 2023
Cartherics’ Acting Chief Scientific Officer, Dr Walid Azar recently attended the 2nd Cell Therapy Potency Assay Summit in Boston. The...
Read More
